Appointment booking for Dr. Manpreet Tiwana, MD is currently not available.Dr. Manpreet Tiwana, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Manpreet Tiwana, MD (she/her) is a Rheumatologist in Somers Point, NJ with over 15 years of experience. What is your opinion of Dr. Manpreet Tiwana, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 15 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Manpreet Tiwana, MD has received over $3,635 which includes payments from the following companies:
$710.10 from Amgen Inc.
$527.72 from AbbVie, Inc.
$398.52 from Mallinckrodt LLC
$314.27 from Pfizer Inc.
$212.20 from Genentech USA, Inc.
$181.37 from GlaxoSmithKline, LLC.
$176.95 from LILLY USA, LLC
$172.55 from E.R. Squibb & Sons, L.L.C.
$132.61 from Novartis Pharmaceuticals Corporation
$91.15 from UCB, Inc.
$77.96 from Questcor Pharmaceuticals
$66.81 from Takeda Pharmaceuticals America, Inc.
$64.92 from Janssen Biotech, Inc.
$64.57 from MEDAC PHARMA, INC.
$52.12 from Horizon Pharma plc
$40.93 from Celgene Corporation
$39.08 from Radius Health, Inc.
$38.00 from Genentech, Inc.
$37.94 from Respiratory Technologies, Inc.
$33.86 from Allergan Inc.
Payments received by Dr. Manpreet Tiwana, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!